|

Rifaximin 550 MG Clinical Trials

2 actively recruiting trials

Pipeline

Phase 4: 1

Top Sponsors

  • Post Graduate Institute of Medical Education and Research, Chandigarh1
  • Institute of Liver and Biliary Sciences, India1

Indications

  • Liver Disease2
  • Minimal Hepatic Encephalopathy1
  • Decompensated Cirrhosis1
  • Hepatic Encephalopathy1
  • Chronic Liver Disease1

Other2 trials

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Phase 4
Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.